{"public_id":"co_499f90d86287919c5257252e45d80fa7","status":"active","merged_into_public_id":null,"resolved_public_id":"co_499f90d86287919c5257252e45d80fa7","name":"trivalent inactivated vaccine (3-IIV)","description":"The standard trivalent inactivated vaccine used as comparator in head-to-head analyses.","aliases":[],"types":["vaccine type"],"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":241185914,"title":"Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis","citation_count":56,"url":"https://sah.borca.ai/papers/241185914"}],"claims":[{"public_id":"cl_91f62fdabcc2947e4e035146a6aa4517","text":"In adults and elderly, trivalent live-attenuated vaccine (3-LAIV) was less efficacious than trivalent inactivated vaccine (3-IIV) in reducing laboratory-confirmed influenza (RR 1.41, 95% CrI 1.04–1.88).","corpus_id":241185914,"url":"https://sah.borca.ai/claims/cl_91f62fdabcc2947e4e035146a6aa4517"},{"public_id":"cl_a02c6e67686deb032ef706b16b0a6c4f","text":"In children, trivalent live-attenuated vaccine (3-LAIV) and trivalent inactivated adjuvanted with MF59/AS03 were more efficacious than trivalent inactivated vaccine (3-IIV) in reducing laboratory-confirmed influenza (RR 0.52 and 0.23 respectively).","corpus_id":241185914,"url":"https://sah.borca.ai/claims/cl_a02c6e67686deb032ef706b16b0a6c4f"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_499f90d86287919c5257252e45d80fa7","url":"https://sah.borca.ai/concepts/co_499f90d86287919c5257252e45d80fa7"}